Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases.

Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102.

LGM Pharma opts to engage with BioPharma Connections for business development services

Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions.

Pharma and biotech customers select service providers for excellence in capabilities, expertise, quality, compatibility, reliability, and service

Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use, allowing Pace to support a growing number of clients throughout the drug development process.

Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, announces a new Solid State Chemistry service.

Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, earned perfect results from its April 2019 FDA inspection.